Seelos Therapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch Seelos Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease (NCT05332678) | Seelos Therapeutics, Inc. | 2023-03-03 |
| STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia (NCT05490563) | Seelos Therapeutics, Inc. | 2022-06-03 |
| A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide (NCT04669665) | Seelos Therapeutics, Inc. | 2020-12-17 |
Track Seelos Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.